{"public_id":"co_e1d689ac9f3e040f1f176213ef3840b3","status":"active","merged_into_public_id":null,"resolved_public_id":"co_e1d689ac9f3e040f1f176213ef3840b3","name":"rectal cancer samples","description":"Tumor specimens collected from operated rectal cancer patients for mutation analysis.","aliases":[],"types":["sample"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":12935948,"title":"Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery","citation_count":29,"url":"https://sah.borca.ai/papers/12935948"}],"claims":[{"public_id":"cl_a87f1f26ef1b6ffe6a80899e6817aab7","text":"KRAS and BRAF mutations were mutually exclusive in the analyzed rectal cancer samples.","corpus_id":12935948,"url":"https://sah.borca.ai/claims/cl_a87f1f26ef1b6ffe6a80899e6817aab7"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_e1d689ac9f3e040f1f176213ef3840b3","url":"https://sah.borca.ai/concepts/co_e1d689ac9f3e040f1f176213ef3840b3"}